Ironwood Pharmaceuticals IRWD Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's total equity?
- Ironwood Pharmaceuticals (IRWD) reported total equity of -$217.14M in Q1 2026.
- How has Ironwood Pharmaceuticals's total equity changed year-over-year?
- Ironwood Pharmaceuticals's total equity increased by 35.0% year-over-year, from -$334.05M to -$217.14M.
- What is the long-term trend for Ironwood Pharmaceuticals's total equity?
- Over 5 years (2020 to 2025), Ironwood Pharmaceuticals's total equity has grown at a 33.1% compound annual growth rate (CAGR), from $62.64M to -$261.84M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.